Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

No trades
See on Supercharts

AXSM fundamentals

Axsome Therapeutics, Inc. revenue breakdown overview

Axsome Therapeutics, Inc. revenue for the last year amounted to 270.60 M USD, the most of which — 270.60 M USD — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 50.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Axsome Therapeutics, Inc. 197.22 M USD, and the year before that — 50.04 M USD.

By source
By country